Abstract
More than 20 years have passed since publication of the pivotal studies of efficacy upon which our use of lithium in acute mania and the prophylaxis of bipolar disorder are based. Since then, two of the most important discoveries about lithium have been the phenomenon of lithium withdrawal mania, and the recognition of permanent neurological sequelae after lithium toxicity. The use of lithium survived earlier criticism from the Institute of Psychiatry (Blackwell & Shepherd, 1968), but the new discoveries call for a reappraisal of the studies and reconsideration of whether lithium has a place in treatment, for which patients it should be recommended, what information and supervision should be given to patients on lithium, and what doctors should be expected to know of it.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference70 articles.
1. A randomised comparison of divalproex oral loading vs. haloperidol in the initial treatment of acute psychotic mania;McElroy;Journal of Clinical Psychiatry,1996
2. Lithium in the treatment of mood disorders;Stern;New England Journal of Medicine,1975
3. Combination of Lithium Carbonate and Haloperidol in Schizo-affective Disorder
4. Depression, Elation, and Lithium Carbonate Responses in Manic Patient Subgroups
5. Does lithium reduce the mortality of recurrent mood disorders?
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献